COMMUNIQUÉS West-GlobeNewswire

Tyme Technologies To Host a Conference Call for the Fourth Quarter and Fiscal Year 2019 Financial and Operating Results on May 29, 2019
24/05/2019
NEW YORK, May 24, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that the company will host a [...]
Emerald Health Therapeutics to Lead International Affairs Council on CBD and Hemp’s Dialog with FDA on CBD Product Policy as Part of the American Trade Association for Cannabis and Hemp
24/05/2019
VANCOUVER, British Columbia, May 24, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has been appointed by the American Trade Association for Cannabis and Hemp (ATACH) to [...]
European Medicine Agency Grants Theratechnologies an Additional Month to Complete Responses Related to Trogarzo® Application
24/05/2019
MONTREAL, May 24, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it requested and obtained from the European Medicines Agency (EMA) an additional month to address new [...]
L’agence européenne des médicaments accorde à Theratechnologies un mois supplémentaire pour répondre aux questions en lien avec la demande d’autorisation de Trogarzo(MD)
24/05/2019
MONTRÉAL , 24 mai 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (Theratechnologies) (TSX: TH) a annoncé aujourd’hui avoir demandé et obtenu de l’agence européenne des médicaments (EMA) afin de répondre aux nouvelles [...]
T2 Biosystems to Participate in Singular Research Spring Select Web Call
24/05/2019
Reiterates 2019 revenue and new contract guidance LEXINGTON, Mass., May 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet [...]
Aclaris Therapeutics to Present at Jefferies 2019 Global Healthcare Conference
24/05/2019
WAYNE, Pa., May 24, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced that [...]
Applied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective Aldose Reductase Inhibitor for Treatment of Diabetic Cardiomyopathy
24/05/2019
Robust clinical and preclinical data featured in prominent Late Breaking Science and Basic and Translational Hot Line sessions NEW YORK, May 24, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a [...]
Surface Oncology Presents Preclinical Data Further Supporting Anti-Tumor Mechanism of CD73 and CD39 Programs at Brisbane Immunotherapy 2019
24/05/2019
Presentation provides updated in vivo efficacy data supporting adenosine reduction for cancer treatment Data also support anti-CD39 candidate’s capability to invoke both innate and adaptive immune anti-tumor activity [...]
Virbac: communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l'Assemblée Générale
24/05/2019
Le 24 mai 2019 Communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale Les actionnaires de VIRBAC sont convoqués en assemblée générale ordinaire et [...]
Bone Therapeutics to present data at TERMIS European Chapter Meeting 2019
24/05/2019
Press release Gosselies, Belgium, 24 May 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, [...]
Bone Therapeutics présentera des données au congrès européen TERMIS 2019
24/05/2019
Communiqué de presse Gosselies, Belgique, le 24 mai 2019, 7am CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux non [...]
Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 12 June 2019 have been made available
24/05/2019
Regulated information Gosselies, Belgium, 24 May 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l’assemblée générale extraordinaire du 12 juin 2019
24/05/2019
Information réglementée Gosselies, Belgique, le 24 mai 2019, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Immuron Prices Underwritten Public Offering of ADSs
24/05/2019
MELBOURNE, Australia,, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for [...]
Nova Leap Health Corp. Posts Record Financial Results for First Quarter 2019
23/05/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 23, 2019 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 [...]
Galectin Therapeutics Reports Alternate Price of Common Stock in Rights Offering
23/05/2019
NORCROSS, Ga., May 23, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported the Alternate Price (i.e., the final [...]
UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And “CBD International Consortium” to Develop Treatment of Opioid Addiction
23/05/2019
MediPharm Labs enters major U.S. led opioid clinical research trial to develop IP and exclusively manufacture CBD gelcaps TORONTO, May 23, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: [...]
Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer
23/05/2019
LAVAL, Québec, May 23, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has completed the previously disclosed issuance of 900,000 common shares from [...]
Immuron Announces Proposed Public Offering of ADSs
23/05/2019
MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the [...]

Pages